Drug Type Synthetic peptide |
Synonyms |
Target |
Mechanism Cell adhesion molecules inhibitors, Immunomodulators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedClinical |
First Approval Date- |
Regulation- |
Molecular FormulaC30H61N2O6P |
InChIKeyLIMZGBKPTHEVDT-UHFFFAOYSA-N |
CAS Registry108225-40-7 |